Manager TitleAgeSince
Chief Executive Officer 49 2025-05-30
Director of Finance/CFO 61 2025-05-30
Sales & Marketing 53 2023-12-31
Director TitleAgeSince
Director/Board Member 62 2019-12-31
Chairman 42 2025-05-31
Director/Board Member 75 2025-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
-1.70%+0.63%-18.93%+11.04% 178B
-1.54%-0.98%-21.45%+15.09% 116B
-0.89%-0.72%-0.19%+35.32% 115B
+3.89%+20.80%-42.56%+8.20% 93.1B
-1.40%-5.21%-3.18%+73.40% 62.09B
+0.04%-0.45%+10.75%+84.19% 55.87B
-0.69%+0.63%+4.27%-22.48% 53.12B
-1.57%+0.60%-13.31%+43.41% 44.22B
-0.66%+3.26%-4.83%-8.81% 33.59B
Average -3.96%+2.27%-9.94%+26.59% 83.45B
Weighted average by Cap. -0.58%+2.37%-13.27%+24.27%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock